Connect with us

Science

Column: How the GOP — with Democratic Party connivance — has undermined a crucial effort to avert the next pandemic

Published

on

Column: How the GOP — with Democratic Party connivance — has undermined a crucial effort to avert the next pandemic

We’ve all come to recognize that committee hearings conducted by the Republican House majority are almost invariably clown shows featuring spittle-flecked posturing by members intent on displaying their ignorance to an appreciative crowd.

Wednesday’s hearing by the Select Subcommittee on the Coronavirus Pandemic was a crystalline example of the genre. It was designed around the grilling of Peter Daszak, the head of EcoHealth Alliance, which oversees international virus research funded by federal agencies.

The members scraped along rock-bottom, but the most telling moment may have been this exchange between Rep. Morgan Griffith (R-Va.) and Daszak. Asked to explain an apparent (but not real) discrepancy in a progress report EcoHealth submitted to the government, Daszak started to answer, but a theatrically fulminating Griffith cut him off.

Our organization, staff, and even my own family were often targeted with false allegations, death threats, break-ins, media harassment, and other damaging acts.

— Peter Daszak, EcoHealth Alliance

Advertisement

“I can give you the answer to your question,” Daszak said.

“I’m going to answer it for you!” Griffith shot back, then outrageously accused Daszak of lying. Daszak didn’t get a chance to reply.

The whole session, more than three hours, went that way. The members kept peppering Daszak with questions about abstruse matters of science and the grant-making process, only to rudely cut him off when he tried to respond. They misquoted him to his face, misrepresented his work, and spouted cocksure inanities showing with every word that, scientifically speaking, they have no idea what they’re talking about.

Advertisement

Ideally, congressional hearings should be fact-finding efforts. This was nothing of the kind. It was an opportunity for posturing by politicians intent only on smearing Daszak and EcoHealth on the pretext of getting to the bottom of the pandemic’s cause.

How do we know this? From the fact that hours before the hearing even began, the subcommittee released a report calling on the National Institutes of Health and the Department of Health and Human Services to “immediately commence suspension and debarment proceedings against both EcoHealth and Dr. Daszak” — in other words, permanently cut them off from federal funding.

One more thing about this ludicrious cabaret act: The Democratic committee members, who should have been standing up for science and scientists, did the opposite by throwing Daszak under the bus.

In his opening statement, Ranking Member Raul Ruiz (D-Indio), attacked the GOP majority’s preposterous position that the U.S. government funded research that created the virus responsible for COVID-19. But he accepted its position that Daszak “sought to deliberately mislead” government regulators.

Ruiz’s statement was echoed by other Democrats, including Rep. Debbie Dingell (D-Mich.). Perhaps they hoped that by allowing Daszak to be drawn and quartered, they might persuade the Republicans to climb down from their evidence-free claims about government complicity in the pandemic’s origins.

Advertisement

Their hearts didn’t seem to be in it, though; they talked as though their main concern was that EcoHealth was spending government funds. They all seemed to be reading from the same ChatGPT script, the key phrase of which was: “poor steward of the taxpayers’ dollars.” Nothing about EcoHealth’s significant achievements in public health.

That makes the Democrats’ performance all the more shameful and cowardly. They’re knowingly participating in a flagrantly fictitious smear campaign.

Let’s examine the background of this display of partisan grandstanding.

Fundamentally, it’s part of a disreputable campaign to demonize responsible scientists such as Anthony Fauci, who retired in 2022 as director of the National Institute of Allergy and Infectious Diseases and was one of the most respected virologists and public health professionals in the world.

Republican leaders and the right wing have tried to turn Fauci into a sinister figure by advancing the absurd proposition that he somehow played a role in creating COVID-19 and spreading it worldwide, and that he masterminded the nation’s anti-pandemic policies, even though he had zero authority to do so.

Advertisement

This is no innocent game; it has subjected Fauci, who was a top pandemic advisor to Donald Trump until his resistance to Trump’s unhinged takes on the pandemic led to his being sidelined at the White House, to death threats and unending vilification on social media.

Daszak has come in for more than his share of character assassination. Social media posts referring to him have included the image of a guillotine. As the pandemic developed, Daszak told the committee in his opening statement Wednesday, “Our organization, staff, and even my own family were often targeted with false allegations, death threats, break-ins, media harassment, and other damaging acts.”

One recent post on X (formerly Twitter) said “the Daszak family should be shot down.” Daszak says he has asked X to cancel the abusive, anonymous account, without success.

What’s the purpose of this campaign? The attack on the credibility of science and scientists has arisen because validated scientific findings about global warming and the origins of COVID-19 cause economic and political discomfort to Big Business and know-nothings who believe that undermining science will advance their political careers. (I’m looking at you, Robert F. Kennedy Jr.)

An essential tenet of the right-wing position on COVID-19 is that the virus escaped from a Chinese laboratory, specifically the Wuhan Institute of Virology. Superficially this is an alluring theory, since the initial outbreak occurred at a wildlife market in that city. But there is absolutely not a speck of evidence for that theory, and scientific research overwhelmingly indicates that the virus reached humans via a spillover from infected wildlife — the path followed by countless viral outbreaks over human history.

Advertisement

Lab leak advocates love to point to a statement FBI Director Christopher Wray made in an interview with Fox News in March 2023 — that the bureau had concluded with “moderate confidence” that the virus had escaped from the Chinese lab. But he cited no evidence; the FBI’s assessment, which had been previously disclosed, had been part of a survey of all U.S. intelligence agencies that largely contradicted the FBI’s position. And in June, a report from the Office of the Director of National Intelligence refuted claims that the Chinese lab had played any role in the pandemic.

Anyway, the WIV isn’t exactly near the market — it’s miles away on the far side of the Yangtze River, in a city as densely populated as Los Angeles, with almost three times L.A.’s population, and a huge regional transportation and commercial hub.

That brings us back to EcoHealth, which was founded in 1971 and has long been an essential clearinghouse for funding for research into “emerging disease threats to the U.S.,” as Daszak said in his opening statement.

That has included providing funds for the WIV and other research in China, where viruses capable of jumping into the human population — as did SARS-CoV-2, the virus behind COVID-19 — are commonly found in bats, and where a vigorous, illicit trade in wildlife brings millions of humans into direct contact with potential disease carriers.

EcoHealth’s relationship with Chinese research institutions was open and aboveboard, and its funnelling U.S. grants to those institutions explicitly approved by the NIH and HHS.

Advertisement

EcoHealth was long considered a gold-plated research organization. “Their grants, when reviewed scientifically, scored at the highest levels in the scientific community,” says Gerald T. Keusch, a former associate director of international research at NIH. “The work they proposed was absolutely stunningly good.”

An internal memo prepared at NIH for a Fauci news conference in January 2020 described EcoHealth as one of “the biggest players in coronavirus work” and Daszak as one of “the world’s experts in … non-human coronaviruses” such as SARS-CoV-2.

As I’ve reported, EcoHealth’s useful and productive role in virological research began to unravel at a news conference April 17, 2020 when a reporter from a right-wing organization mentioned to then-President Trump that NIH had given a $3.7-million grant to the Wuhan Institute of Virology. (Actually, the WIV grant, which was channeled from a larger EcoHealth grant, was only $600,000).

Trump, sensing an opportunity to show a strong hand against China and advance his effort to blame the Chinese for the pandemic, responded: “We will end that grant very quickly.” The NIH terminated the full EcoHealth grant one week later prompting a backlash from the scientific community, including an open letter signed by 77 Nobel laureates who saw the action as a flagrantly partisan interference in government funding of scientific research.

The HHS inspector general found the termination to be “improper.” NIH reinstated the grant, but immediately suspended it until EcoHealth met several conditions that were manifestly beyond its capability, as they involved its demanding information from the Chinese government that it had no right to receive.

Advertisement

The EcoHealth grant was finally restored in May 2023. By then, EcoHealth no longer had a relationship with WIV, which had been barred from receiving any NIH funds. Still, at the time I celebrated the end of a Trump-inspired three-year shutdown of field work to examine how viruses move from rural wildlife to humans. Unfortunately, that was premature.

Since then, Daszak told me, NIH has continued to erect bureaucratic barriers preventing EcoHealth from accessing funds under the grant, in effect freezing its ability to work.

At Wednesday’s hearing, the GOP tried to pretend that the decision to terminate the grant was all NIH’s idea. “This was not ended by the president of the United States,” declared Mitchell Benzine, counsel to the subcommittee’s Republican majority.

Benzine has a suspiciously short memory. According to documents that the subcommittee itself made public, on Jan. 5 this year, Benzine himself elicited closed-door testimony from Lawrence Tabak, a top NIH official, that after that 2020 news conference “[Trump Chief of Staff] Mark Meadows called the Office of General Counsel at HHS, who then called Dr. Tabak, who then called Dr. [Michael] Lauer, who was instructed to cancel the grant.” Can’t get a much more direct line from Trump to NIH than that.

(Lauer is an NIH functionary who has been a key figure placing the bureaucreatic obstacle course before EcoHealth; my request for comment from him and Tabak was met with a no-comment from NIH.)

Advertisement

Wednesday’s hearing largely recapitulated the attacks on EcoHealth that have been floating in the right-wing fever swamp for four years now. They include a litany of minor bureaucratic snafus, such as a grant progress report that missed a deadline (Daszak said the problem was a glitch in an NIH web portal that prevented it from being submitted on time).

One key assertion is that EcoHealth was funding “gain of function” research at the Wuhan Institute. “Gain of function” is a widely misunderstood term that has become a shibboleth for proponents of the lab-leak hypothesis, who use it as an all-purpose symbol of sinister behavior, like “critical race theory” or “DEI” (diversity, equity and inclusion).

Technically speaking, gain-of-function is a method of modifying a pathogen in the lab to gauge its infectiousness in humans, the better to develop countermeasures such as vaccines. The right-wing claims that such research in China funded by NIH and EcoHealth created SARS-CoV-2, which then escaped into the wild.

There’s no evidence that the Wuhan lab did anything like that, and experienced virologists have questioned whether it’s even technically possible to have created the SARS2 virus given today’s level of knowledge. The U.S. government placed a moratorium on gain-of-function research from 2014 through 2017 to allow for the development of best-practice protocols.

NIH explicitly confirmed to EcoHealth that the studies it was funding didn’t qualify as gain-of-function under its own definition. That didn’t stop the committee members from wasting long swaths of their session accusing Daszak of secretly funding such experiments.

Advertisement

The attacks on EcoHealth appall scientists and public health experts who know that the organization’s work in identifying potential pandemic sources and crafting responses has never been more important. Agricultural authorities are dealing with the spread of a bird flu virus into cattle herds, another case of species-to-species, or zoonotic, viral transmission.

Given the bipartisan attacks against it, whether EcoHealth can avoid being cut off from all government funding is an open question. But that only underscores the supine irresponsibility with which Democrats have bought into the right wing’s attack on the organization and its crucial work.

“We now have zoonotic threats emerging at an accelerating cadence,” says Peter Hotez, a molecular virologist who is dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston.

“This is a time when we need to be doubling down and expanding our global virus surveillance networks,” Hotez told me. “By making up allegations, they’re undermining the work of EcoHealth and other organizations committed to understanding how viruses are jumping from animals to humans. We’re creating incredible vulnerability for ourselves. They’re damaging our national security. That to me is unforgivable — that they’re willing to jeopardize national security for political expedience.”

Advertisement

Science

A virus without a vaccine or treatment is hitting California. What you need to know

Published

on

A virus without a vaccine or treatment is hitting California. What you need to know

A respiratory virus that doesn’t have a vaccine or a specific treatment regimen is spreading in some parts of California — but there’s no need to sound the alarm just yet, public health officials say.

A majority of Northern California communities have seen high concentrations of human metapneumovirus, or HMPV, detected in their wastewater, according to data from the WastewaterScan Dashboard, a public database that monitors sewage to track the presence of infectious diseases.

A Los Angeles Times data analysis found the communities of Merced in the San Joaquin Valley, and Novato and Sunnyvale in the San Francisco Bay Area have seen increases in HMPV levels in their wastewater between mid-December and the end of February.

HMPV has also been detected in L.A. County, though at levels considered low to moderate at this point, data show.

While HMPV may not necessarily ring a bell, it isn’t a new virus. Its typical pattern of seasonal spread was upended by the COVID-19 pandemic, and its resurgence could signal a return to a more typical pre-coronavirus respiratory disease landscape.

Advertisement

Here’s what you need to know.

What is HMPV?

HMPV was first detected in 2001, according to the U.S. Centers for Disease Control and Prevention. It’s transmitted by close contact with someone who is infected or by touching a contaminated surface, said Dr. Neha Nanda, chief of infectious diseases and hospital epidemiologist for Keck Medicine of USC.

Like other respiratory illnesses, such as influenza, HMPV spreads and is more durable in colder temperatures, infectious-disease experts say.

Human metapneumovirus cases commonly start showing up in January before peaking in March or April and then tailing off in June, said Dr. Jessica August, chief of infectious diseases at Kaiser Permanente Santa Rosa.

However, as was the case with many respiratory viruses, COVID disrupted that seasonal trend.

Advertisement

Why are we talking about HMPV now?

Before the pandemic hit in 2020, Americans were regularly exposed to seasonal viruses like HMPV and developed a degree of natural immunity, August said.

That protection waned during the pandemic, as people stayed home or kept their distance from others. So when people resumed normal activities, they were more vulnerable to the virus. Unlike other viruses, there isn’t a vaccine for human metapneumovirus.

“That’s why after the pandemic we saw record-breaking childhood viral illnesses because we lacked the usual immunity that we had, just from lack of exposure,” August said. “All of that also led to longer viral seasons, more severe illness. But all of these things have settled down in many respects.”

In 2024, the national test positivity for HMPV peaked at 11.7% at the end of March, according to the National Respiratory and Enteric Virus Surveillance System. The following year’s peak was 7.15% in late April.

So far this year, the highest test positivity rate documented was 6.1%, reported on Feb. 21 — the most recent date for which complete data are available.

Advertisement

While the seasonal spread of viruses like HMPV is nothing new, people became more aware of infectious diseases and how to prevent them during the pandemic, and they’ve remained part of the public consciousness in the years since, August and Nanda said.

What are the symptoms of HMPV?

Most people won’t go to the doctor if they have HMPV because it typically causes mild, cold-like symptoms that include cough, fever, nasal congestion and sore throat.

HMPV infection can progress to:

  • An asthma attack and reactive airway disease (wheezing and difficulty breathing)
  • Middle ear infections behind the ear drum
  • Croup, also known as “barking” cough — an infection of the vocal cords, windpipe and sometimes the larger airways in the lungs
  • Bronchitis
  • Fever

Anyone can contract human metapneumovirus, but those who are immunocompromised or have other underlying medical conditions are at particular risk of developing severe disease — including pneumonia. Young children and older adults are also considered higher-risk groups, Nanda said.

What is the treatment for HMPV?

There is no specified treatment protocol or antiviral medication for HMPV. However, it’s common for an infection to clear up on its own and treatment is mostly geared toward soothing symptoms, according to the American Lung Assn.

A doctor will likely send you home and tell you to rest and drink plenty of fluids, Nanda said.

Advertisement

If symptoms worsen, experts say you should contact your healthcare provider.

How to avoid contracting HMPV

Infectious-disease experts said the best way to avoid contracting HMPV is similar to preventing other respiratory illnesses.

The American Lung Assn.’s recommendations include:

  • Wash your hands often with soap and water. If that’s not available, clean your hands with an alcohol-based hand sanitizer.
  • Clean frequently touched surfaces.
  • Crack open a window to improve air flow in crowded spaces.
  • Avoid being around sick people if you can.
  • Avoid touching your eyes, nose and mouth.

Assistant data and graphics editor Vanessa Martínez contributed to this report.

Advertisement
Continue Reading

Science

After rash of overdose deaths, L.A. banned sales of kratom. Some say they lost lifeline for pain and opioid withdrawal

Published

on

After rash of overdose deaths, L.A. banned sales of kratom. Some say they lost lifeline for pain and opioid withdrawal

Nearly four months ago, Los Angeles County banned the sale of kratom, as well as 7-OH, the synthetic version of the alkaloid that is its active ingredient. The idea was to put an end to what at the time seemed like a rash of overdose deaths related to the drug.

It’s too soon to tell whether kratom-related deaths have dissipated as a result — or, really, whether there was ever actually an epidemic to begin with. But many L.A. residents had become reliant on kratom as something of a panacea for debilitating pain and opioid withdrawal symptoms, and the new rules have made it harder for them to find what they say has been a lifesaving drug.

Robert Wallace started using kratom a few years ago for his knees. For decades he had been in pain, which he says stems from his days as a physical education teacher for the Glendale Unified School District between 1989 and 1998, when he and his students primarily exercised on asphalt.

In 2004, he had arthroscopic surgery on his right knee, followed by varicose vein surgery on both legs. Over the next couple of decades, he saw pain-management specialists regularly. But the primary outcome was a growing dependence on opioid-based painkillers. “I found myself seeking doctors who would prescribe it,” he said.

He leaned on opioids when he could get them and alcohol when he couldn’t, resulting in a strain on his marriage.

Advertisement

When Wallace was scheduled for his first knee replacement in 2021 (he had his other knee replaced a few years later), his brother recommended he take kratom for the post-surgery pain.

It seemed to work: Wallace said he takes a quarter of a teaspoon of powdered kratom twice a day, and it lets him take charge of managing his pain without prescription painkillers and eases harsh opiate-withdrawal symptoms.

He’s one of many Angelenos frustrated by recent efforts by the county health department to limit access to the drug. “Kratom has impacted my life in only positive ways,” Wallace told The Times.

For now, Wallace is still able to get his kratom powder, called Red Bali, by ordering from a company in Florida.

However, advocates say that the county crackdown on kratom could significantly affect the ability of many Angelenos to access what they say is an affordable, safer alternative to prescription painkillers.

Advertisement

Kratom comes from the leaves of a tree native to Southeast Asia called Mitragyna speciosa. It has been used for hundreds of years to treat chronic pain, coughing and diarrhea as well as to boost energy — in low doses, kratom appears to act as a stimulant, though in higher doses, it can have effects more like opioids.

Though advocates note that kratom has been used in the U.S. for more than 50 years for all sorts of health applications, there is limited research that suggests kratom could have therapeutic value, and there is no scientific consensus.

Then there’s 7-OH, or 7-Hydroxymitragynine, a synthetic alkaloid derived from kratom that has similar effects and has been on the U.S. market for only about three years. However, because of its ability to bind to opioid receptors in the body, it has a higher potential for abuse than kratom.

Public health officials and advocates are divided on kratom. Some say it should be heavily regulated — and 7-OH banned altogether — while others say both should be accessible, as long as there are age limitations and proper labeling, such as with alcohol or cannabis.

In the U.S., kratom and 7-OH can be found in all sorts of forms, including powder, capsules and liquids — though it depends on exactly where you are in the country. Though the Food and Drug Administration has recommended that 7-OH be included as a Schedule 1 controlled substance under the Controlled Substances Act, that hasn’t been made official. And the plant itself remains unscheduled on the federal level.

Advertisement

That has left states, counties and cities to decide how to regulate the substances.

California failed to approve an Assembly bill in 2024 that would have required kratom products to be registered with the state, have labeling and warnings, and be prohibited from being sold to anyone younger than 21.

It would also have banned products containing synthetic versions of kratom alkaloids. The state Legislature is now considering another bill that basically does the same without banning 7-OH — while also limiting the amount of synthetic alkaloids in kratom and 7-OH products sold in the state.

“Until kratom and its pharmacologically active key ingredients mitragynine and 7-OH are approved for use, they will remain classified as adulterants in drugs, dietary supplements and foods,” a California Department of Public Health spokesperson previously told The Times.

On Tuesday, California Gov. Gavin Newsom announced that the state’s efforts to crack down on kratom products has resulted in the removal of more than 3,300 kratom and 7-OH products from retail stores. According to a news release from the governor’s office, there has been a 95% compliance rate from businesses in removing the products.

Advertisement

(Los Angeles Times photo illustration; source photos by Getty Images)

Newsom has equated these actions to the state’s efforts in 2024 to quash the sale of hemp products containing cannabinoids such as THC. Under emergency state regulations two years ago, California banned these specific hemp products and agents with the state Department of Alcoholic Beverage Control seized thousands of products statewide.

Since the beginning of 2026, there have been no reported violations of the ban on sales of such products.

“We’ve shown with illegal hemp products that when the state sets clear expectations and partners with businesses, compliance follows,” Newsom said in a statement. “This effort builds on that model — education first, enforcement where necessary — to protect Californians.”

Advertisement

Despite the state’s actions, the Los Angeles County Board of Supervisors is still considering whether to regulate kratom, or ban it altogether.

The county Public Health Department’s decision to ban the sale of kratom didn’t come out of nowhere. As Maral Farsi, deputy director of the California Department of Public Health, noted during a Feb. 18 state Senate hearing, the agency “identified 362 kratom-related overdose deaths in California between 2019 and 2023, with a steady increase from 38 in 2019 up to 92 in 2023.”

However, some experts say those numbers aren’t as clear-cut as they seem.

For example, a Los Angeles Times investigation found that in a number of recent L.A. County deaths that were initially thought to be caused by kratom or 7-OH, there wasn’t enough evidence to say those drugs alone caused the deaths; it might be the case that the danger is in mixing them with other substances.

Meanwhile, the actual application of this new policy seems to be piecemeal at best.

Advertisement

The county Public Health Department told The Times it conducted 2,696 kratom-related inspections between Nov. 10 and Jan. 27, and found 352 locations selling kratom products. The health department said the majority stopped selling kratom after those inspections; there were nine locations that ignored the warnings, and in those cases, inspectors impounded their kratom products.

But the reality is that people who need kratom will buy it on the black market, drive far enough so they get to where it’s sold legally or, like Wallace, order it online from a different state.

For now, retailers who sell kratom products are simply carrying on until they’re investigated by county health inspectors.

Ari Agalopol, a decorated pianist and piano teacher, saw her performances and classes abruptly come to a halt in 2012 after a car accident resulted in severe spinal and knee injuries.

“I tried my best to do traditional acupuncture, physical therapy and hydrocortisone shots in my spine and everything,” she said. “Finally, after nothing was working, I relegated myself to being a pain-management patient.”

Advertisement

She was prescribed oxycodone, and while on the medication, battled depression, anhedonia and suicidal ideation. She felt as though she were in a fog when taking oxycodone, and when it ran out, ”the pain would rear its ugly head.” Agalopol struggled to get out of bed daily and could manage teaching only five students a week.

Then, looking for alternatives to opioids, she found a Reddit thread in which people were talking up the benefits of kratom.

“I was kind of hesitant at first because there’re so many horror stories about 7-OH, but then I researched and I realized that the natural plant is not the same as 7-OH,” she said.

She went to a local shop, Authentic Kratom in Woodland Hills, and spoke to a sales associate who helped her decide which of the 47 strains of kratom it sold would best suit her needs.

Agalopol currently takes a 75-milligram dose of mitragynine, the primary alkaloid in kratom, when necessary. It has enabled her to get back to where she was before her injury: teaching 40 students a week and performing every weekend.

Advertisement

Agalopol believes the county hasn’t done its homework on kratom. “They’re just taking these actions because of public pressure, and public pressure is happening because of ignorance,” she said.

During the course of reporting this story, Authentic Kratom has shut down its three locations; it’s unclear if the closures are temporary. The owner of the business declined to comment on the matter.

When she heard the news of the recent closures, Agalopol was seething. She told The Times she has enough capsules of kratom for now, but when she runs out, her option will have to be Tylenol and ibuprofen, “which will slowly kill my liver.”

“Prohibition is not a public health strategy,” said Jackie Subeck, executive director of 7-Hope Alliance, a nonprofit that promotes safe and responsible access to 7-OH for consumers, at the Feb. 18 Senate hearing. “[It’s] only going to make things worse, likely resulting in an entirely new health crisis for Californians.”

Advertisement
Continue Reading

Science

There were 13 full-service public health clinics in L.A. County. Now there are 6

Published

on

There were 13 full-service public health clinics in L.A. County. Now there are 6

Because of budget cuts, the Los Angeles County Department of Public Health has ended clinical services at seven of its public health clinic sites.

As of Feb. 27, the county is no longer providing services such as vaccinations, sexually transmitted infection testing and treatment, or tuberculosis diagnosis and specialty TB care at the affected locations, according to county officials and a department fact sheet.

The sites losing clinical services are Antelope Valley in Lancaster; the Center for Community Health (Leavy) in San Pedro, Curtis R. Tucker in Inglewood, Hollywood-Wilshire, Pomona, Dr. Ruth Temple in South Los Angeles, and Torrance. Services will continue to be provided by the six remaining public health clinics, and through nearby community clinics.

The changes are the result of about $50 million in funding losses, according to official county statements.

Advertisement

“That pushed us to make the very difficult decision to end clinical services at seven of our sites,” said Dr. Anish Mahajan, chief deputy director of the L.A. County Department of Public Health.

Mahajan said the department selected clinics with relatively lower patient volumes. Over the last month, he said, the department has sent letters to patients about the changes, and referred them to unaffected county clinics, nearby federally qualified health centers or other community providers. According to Mahajan, for tuberculosis patients, particularly those requiring directly observed therapy, public health nurses will continue visiting patients.

Public health clinics form part of the county’s healthcare safety net, serving low-income residents and those with limited access to care. Officials said that about half of the patients the county currently sees across its clinics are uninsured.

Mahajan noted that the clinics were established decades ago, before the Affordable Care Act expanded Medi-Cal coverage and increased the number of federally qualified health centers. He said that as more residents gained access to primary care, utilization at some county-run clinics declined.

“Now that we have a more sophisticated safety net, people often have another place to go for their full range of care,” he said.

Advertisement

Still, the closures have unsettled providers who work closely with local vulnerable populations.

“I hate to see any services that serve our at-risk and homeless community shut down,” said Mark Hood, chief executive of Union Rescue Mission in downtown Los Angeles. “There’s so much need out there, so it always is going to create hardship for the people that actually need the help the most.”

Union Rescue Mission does not receive government funding for its healthcare services, Hood said. The mission’s clinics are open not only to shelter guests, up to 1,000 people nightly, but also to people living on the streets who walk in seeking care.

Its dental clinic alone sees nearly 9,000 patients a year, Hood said.

“We haven’t seen it yet, but I expect in the coming days and weeks we’ll see more people coming through our doors looking for help,” he said. “They’re going to have to find help somewhere.” Hood said women experiencing homelessness are especially vulnerable when preventive care, including sexual and reproductive health services, becomes harder to access.

Advertisement

County officials said staffing impacts so far have been managed through reassignment rather than layoffs. Roughly 200 to 300 positions across the department have been eliminated amid funding cuts, officials said, though many were vacant. About 120 employees whose positions were affected have been reassigned; according to Mahajan, no one has been laid off.

The clinic closures come amid broader fiscal uncertainty. Mahajan said that due to the Trump administration’s “Big Beautiful Bill,” Los Angeles County could lose $2.4 billion over the next several years. That funding, he said, supports clinics, hospitals and community clinic partners now absorbing patients who previously went to the clinics that closed on Feb. 27.

In response, the L.A. County Board of Supervisors has backed a proposed half-cent sales tax measure that would generate hundreds of millions of dollars annually for healthcare and public health services. Voters are expected to consider the measure in June.

Advertisement
Continue Reading

Trending